Osteonic Co. Ltd (226400) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Osteonic Co. Ltd (226400) has a cash flow conversion efficiency ratio of 0.017x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.09 Billion ≈ $738.58K USD) by net assets (₩63.89 Billion ≈ $43.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 226400 net asset quality index to measure how much of total assets are equity-financed.
Osteonic Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Osteonic Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Osteonic Co. Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Osteonic Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Osteonic Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Amiad Water Systems Ltd
TA:AMD
|
0.017x |
|
Grupo Mexicano de Desarrollo S.A.B
MX:GMD
|
0.036x |
|
MedFirst Healthcare Services lnc
TWO:4175
|
0.076x |
|
IDREAMSKY TE+H. DL-0001
F:08IA
|
N/A |
|
RENERGEN LTD CDI/1:1
F:996
|
N/A |
|
Aemulus Holdings Bhd
KLSE:0181
|
-0.202x |
|
Alliance Aviation Services Ltd
AU:AQZ
|
-0.016x |
|
E & M Computing Ltd
TA:EMCO
|
0.118x |
Annual Cash Flow Conversion Efficiency for Osteonic Co. Ltd (2015–2024)
The table below shows the annual cash flow conversion efficiency of Osteonic Co. Ltd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see 226400 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩59.32 Billion ≈ $40.20 Million |
₩4.72 Billion ≈ $3.20 Million |
0.080x | -0.34% |
| 2023-12-31 | ₩51.88 Billion ≈ $35.16 Million |
₩4.14 Billion ≈ $2.81 Million |
0.080x | -26.91% |
| 2022-12-31 | ₩36.50 Billion ≈ $24.74 Million |
₩3.99 Billion ≈ $2.70 Million |
0.109x | +31.70% |
| 2021-12-31 | ₩35.53 Billion ≈ $24.08 Million |
₩2.95 Billion ≈ $2.00 Million |
0.083x | -26.84% |
| 2020-12-31 | ₩24.28 Billion ≈ $16.46 Million |
₩2.75 Billion ≈ $1.86 Million |
0.113x | +233.50% |
| 2019-12-31 | ₩28.96 Billion ≈ $19.62 Million |
₩-2.46 Billion ≈ $-1.67 Million |
-0.085x | -861.84% |
| 2018-12-31 | ₩28.50 Billion ≈ $19.31 Million |
₩317.53 Million ≈ $215.19K |
0.011x | +110.40% |
| 2017-12-31 | ₩7.43 Billion ≈ $5.03 Million |
₩-795.80 Million ≈ $-539.30K |
-0.107x | +27.68% |
| 2016-12-31 | ₩11.68 Billion ≈ $7.91 Million |
₩-1.73 Billion ≈ $-1.17 Million |
-0.148x | +26.46% |
| 2015-12-31 | ₩6.35 Billion ≈ $4.30 Million |
₩-1.28 Billion ≈ $-866.78K |
-0.201x | -- |
About Osteonic Co. Ltd
Osteonic Co., Ltd. develops, manufactures, and sells bone fixation systems. It offers CMF systems, including neuro plating systems, maxillofacial plating systems, mandible plating systems, IMF screws, power screw drivers, 90 angled screw driver, customized neuro 3D mesh, and mandible reconstruction plates under the OPTIMUS and Real FIT brand names; and biodegradable CMF plating systems under the … Read more